In a unique partnership between the Intrepid Museum and FARO Technologies, one of America's most historic aircraft carriers has been digitally preserved with millimeter-level precision, creating a ...

As the science of Crohn’s disease (CD) rapidly evolves, the American Gastroenterological Association (AGA) has issued a living guideline on the pharmacologic management of moderately to severely ...

PythoC lets you use Python as a C code generator, but with more features and flexibility than Cython provides. Here’s a first look at the new C code generator for Python. Python and C share more than ...

In 2020, Apple stopped using Intel chips and switched to its own Apple Silicon chips for all Mac computers. These new chips offer better performance and use less power. Now, less than five years later ...

Nov 25 (Reuters) - Meta Platforms (META.O), opens new tab is in talks with Google to spend billions of dollars on the Alphabet (GOOGL.O), opens new tab-owned company's chips for use in its data ...

The US military has undertaken a campaign against alleged drug trafficking boats in the Pacific Ocean and Caribbean Sea using a variety of drones, gunships, and fighter jets, according to people ...

Trump wants Nvidia's advanced Blackwell chips for US companies only Nvidia has said it would supply Blackwell chips to South Korea Trump had hinted at scaled-down Blackwell chip sales to China in ...

Weeks after a $100 billion agreement to use computer chips from Nvidia, OpenAI has signed a similar deal with a rival chipmaker. By Cade Metz Reporting from San Francisco Late last month, OpenAI ...

Python is one of the most popular programming languages in the world today, with millions of developers using it for web development, data science, machine learning, automation, and more. If you’ve ...

# International endpoint key export DASHSCOPE_API_KEY="sk-..." Qwen3-ASR-Toolkit turns Qwen3-ASR-Flash into a practical long-audio pipeline by combining VAD-based segmentation, FFmpeg normalization ...

Cemiplimab plus chemotherapy doubled the 5-year survival rate compared to chemotherapy alone in advanced NSCLC patients. The EMPOWER-Lung 3 trial showed a median overall survival of 21.1 months with ...